Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.
暂无分享,去创建一个
R. Hautmann | M. Graefen | H. Huland | S. Hautmann | A. Erbersdobler | R. Henke | M. Straub | R E Hautmann | H Huland | S H Hautmann | S Conrad | R P Henke | A Erbersdobler | J Simon | M Straub | M Graefen | S. Conrad | J. Simon
[1] T. Stamey,et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.
[2] M W Kattan,et al. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. , 1996, The Journal of urology.
[3] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.
[4] G. Haas,et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. , 1993, The Journal of urology.
[5] T. Chun. Coincidence of bladder and prostate cancer. , 1997, The Journal of urology.
[6] L. Baert,et al. Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view. , 1997, The Journal of urology.
[7] T. Stamey,et al. Capsular Penetration in Prostate Cancer. Significance for Natural History and Treatment , 1990, The American journal of surgical pathology.
[8] J. Moul,et al. Prostate‐specific antigen‐detected prostate cancer (Stage T1c): An analysis of whole‐mount prostatectomy specimens , 1997, The Prostate.
[9] H. Levin,et al. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer , 1989, Cancer.
[10] J Whitney,et al. Testing for differences with the nonparametric Mann-Whitney U test. , 1997, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.
[11] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[12] M. Soloway,et al. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. , 1996, European urology.
[13] E. Bergstralh,et al. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. , 1996, The Journal of urology.
[14] D. Grignon,et al. Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. , 1989, Urology.
[15] W. Fair,et al. Incidence and clinical significance of false-negative sextant prostate biopsies. , 1998, The Journal of urology.
[16] Richard A. Szucs,et al. TNM Classification of Malignant Tumors. 5th ed , 1998 .
[17] D. Chan,et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. , 1998, The Journal of urology.
[18] N. Breslow,et al. Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France , 1977, International journal of cancer.
[19] L. M. Franks. Latent carcinoma of the prostate. , 1954, The Journal of pathology and bacteriology.
[20] T. Stamey,et al. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. , 1989, The Journal of urology.
[21] A. Sagalowsky,et al. Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. , 1997, Urology.
[22] D. Ornstein,et al. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. , 1997, JAMA.
[23] T. Stamey,et al. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. , 1990, The Journal of urology.